Jim Lee
Chief Medical Officer
Biopharmaceuticals
Roivant Sciences
Switzerland
Biography
Jim Lee joined Dermavant in 2016 from GlaxoSmithKline where he served as head of the dermatology clinical development group since 2011. Jim began his career in pharmaceutical medicine over 17 years ago and has held positions of increasing responsibility in clinical development and medical affairs at GSK, Graceway Pharmaceuticals, Johnson and Johnson, and 3M Pharmaceuticals. His leadership and contributions in the development of a number of dermatological treatments, including ALDARA® and STELARA®, have helped Jim become one of the leaders in dermatology development. Jim earned a B.A. in biochemistry from Carleton College, in Northfield, Minnesota and graduated from the Medical Scholars Program at the University of Illinois, receiving a Ph.D. in biochemistry and an M.D. from the College of Medicine.
Research Interest
Biochemistry
